| Literature DB >> 32591093 |
Rahul Peravali1, Saurav Acharya2, Syed Hasan Raza3, Debendra Pattanaik3, Milton Barry Randall4.
Abstract
Dermatomyositis is an inflammatory disorder involving muscle and skin. Similar to many other autoimmune diseases, environmental factors appear to trigger the onset of disease in some cases. Many drugs have been reported to be associated with dermatomyositis, and rarely infections have been described as potential triggering agents. Here we are describing a case of dermatomyositis that developed after doxycycline and levofloxacin use, who also had recent Epstein-Barr virus infection. Dermatomyositis associated with doxycycline or levofloxacin use has not yet been described in the literature, while reports of dermatomyositis after Epstein-Barr virus infection have been rare and limited to juvenile dermatomyositis or in association with cancer. It is important for clinicians to be aware of this rare association so that the diagnosis and treatment can be exercised promptly.Entities:
Keywords: Antibiotics associated dermatomyositis; Dermatomyositis; EBV associated dermatomyositis
Mesh:
Substances:
Year: 2020 PMID: 32591093 PMCID: PMC7687046 DOI: 10.1016/j.amjms.2020.05.011
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378